Autolus Therapeutics plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AUTL Nasdaq 2836 www.autolus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Autolus Therapeutics plc

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - Jul 16th, 2025 9:24 am
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 15th, 2025 2:05 pm
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - Jul 15th, 2025 9:09 am
European Equities Traded in the US as ADRs Edge Up in Monday Trading - Jul 14th, 2025 9:13 am
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Jul 9th, 2025 9:04 am
European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading - Jul 8th, 2025 9:08 am
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading - Jul 7th, 2025 9:06 am
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading - Jul 1st, 2025 8:58 am
Autolus Therapeutics (AUTL) Presents Positive Long-Term Obe-cel Data at EHA 2025 - Jun 29th, 2025 1:03 am
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading - Jun 25th, 2025 9:04 am
Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10 - Jun 24th, 2025 3:34 pm
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Jun 24th, 2025 9:08 am
Ardelyx Leads The Pack Of 3 Promising Penny Stocks - Jun 24th, 2025 6:05 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading - Jun 23rd, 2025 9:14 am
Syncona Ltd (LSE:SYNC) Full Year 2025 Earnings Call Highlights: Navigating Market Challenges ... - Jun 20th, 2025 1:00 am
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - Jun 17th, 2025 9:03 am
Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress - Jun 12th, 2025 12:00 am
Autolus Therapeutics to Participate in Upcoming Investor Conferences - May 29th, 2025 2:05 pm
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - May 23rd, 2025 6:30 am
Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential - May 20th, 2025 11:52 am